We are live on
!
Find out more
Vertex Pharmaceuticals
VRTX
VRTX
1,206 hedge funds and large institutions have $74.9B invested in Vertex Pharmaceuticals in 2023 Q1 according to their latest regulatory filings, with 110 funds opening new positions, 459 increasing their positions, 466 reducing their positions, and 95 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more ownership
Funds ownership: →
2% less repeat investments, than reductions
Existing positions increased: 459 | Existing positions reduced: 466
1% less funds holding
Funds holding: 1,221 → 1,206 (-15)
14% less funds holding in top 10
Funds holding in top 10: 28 → 24 (-4)
Holders
1,206
Holding in Top 10
24
Calls
$447M
Puts
$355M
Top Buyers
| 1 | +$1.01B | |
| 2 | +$568M | |
| 3 | +$350M | |
| 4 |
JP Morgan Chase
New York
|
+$261M |
| 5 |
Capital Research Global Investors
Los Angeles,
California
|
+$243M |
Top Sellers
| 1 | -$477M | |
| 2 | -$255M | |
| 3 | -$209M | |
| 4 |
Man Group
London,
United Kingdom
|
-$173M |
| 5 |
Jennison Associates
New York
|
-$161M |